Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Alignment Healthcare ( (ALHC) ) has provided an update.
At the annual meeting held on June 5, 2025, Alignment Healthcare‘s stockholders voted on several key proposals. Three Class I directors were elected to serve until 2028, Deloitte & Touche LLP’s appointment as the accounting firm for 2025 was ratified, and the executive compensation plan was approved, reflecting confidence in the company’s leadership and strategic direction.
The most recent analyst rating on (ALHC) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Alignment Healthcare stock, see the ALHC Stock Forecast page.
Spark’s Take on ALHC Stock
According to Spark, TipRanks’ AI Analyst, ALHC is a Neutral.
Alignment Healthcare’s overall score is driven by strong earnings call results and revenue growth, yet is held back by persistent profitability challenges and weak technical indicators. The raised guidance and strategic market expansion are positive, but concerns about valuation and leadership transition create uncertainty.
To see Spark’s full report on ALHC stock, click here.
More about Alignment Healthcare
Alignment Healthcare, Inc. operates in the healthcare industry, focusing on providing healthcare services and solutions. The company is known for its innovative approach to healthcare, aiming to improve patient outcomes and streamline healthcare delivery.
Average Trading Volume: 3,339,650
Technical Sentiment Signal: Buy
Current Market Cap: $2.9B
Learn more about ALHC stock on TipRanks’ Stock Analysis page.